{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:46:45Z","timestamp":1793854005184,"version":"4.6.1"},"reference-count":134,"publisher":"European Respiratory Society (ERS)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2011,1,5]]},"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:p>A collaboration of multidisciplinary experts on the delivery of pharmaceutical aerosols was facilitated by the European Respiratory Society (ERS) and the International Society for Aerosols in Medicine (ISAM), in order to draw up a consensus statement with clear, up-to-date recommendations that enable the pulmonary physician to choose the type of aerosol delivery device that is most suitable for their patient. The focus of the consensus statement is the patient-use aspect of the aerosol delivery devices that are currently available.<\/jats:p><jats:p>The subject was divided into different topics, which were in turn assigned to at least two experts. The authors searched the literature according to their own strategies, with no central literature review being performed. To achieve consensus, draft reports and recommendations were reviewed and voted on by the entire panel.<\/jats:p><jats:p>Specific recommendations for use of the devices can be found throughout the statement. Healthcare providers should ensure that their patients can and will use these devices correctly. This requires that the clinician: is aware of the devices that are currently available to deliver the prescribed drugs; knows the various techniques that are appropriate for each device; is able to evaluate the patient's inhalation technique to be sure they are using the devices properly; and ensures that the inhalation method is appropriate for each patient.<\/jats:p>","DOI":"10.1183\/09031936.00166410","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T03:53:01Z","timestamp":1297396381000},"page":"1308-1417","source":"Crossref","is-referenced-by-count":686,"title":["What the pulmonary specialist should know about the new inhalation therapies"],"prefix":"10.1183","volume":"37","author":[{"given":"B.L.","family":"Laube","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.H.C.","family":"de Jongh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.G.","family":"Devadason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dhand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Diot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Everard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Navalesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Voshaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Chrystyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2011,2,10]]},"reference":[{"key":"2024102020345281000_37.6.1308.1","unstructured":"Global Initiative for Asthma (GINA), National Heart Lung and Blood Institute, National Institutes of Health. GINA report. Global strategy for asthma management and prevention. Bethesda, National Institutes of Health, 2006."},{"key":"2024102020345281000_37.6.1308.2","unstructured":"Global Initiative for Obstructive Lung Disease (GOLD), National Heart Lung and Blood Institute, National Institutes of Health. GOLD report. Global strategy for diagnosis, management and prevention of COPD. Bethesda, National Institutes of Health, 2009."},{"key":"2024102020345281000_37.6.1308.3","unstructured":"BTS\/SIGN. British guidelines on the management of asthma. London and Edinburgh, British Thoracic Society and Scottish Intercollegiate Guidelines Network, 2008."},{"key":"2024102020345281000_37.6.1308.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200705-664OC"},{"key":"2024102020345281000_37.6.1308.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2009.04.005"},{"key":"2024102020345281000_37.6.1308.6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta5260","article-title":"Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airway disease; a systematic review of the literature","volume":"5","author":"Brocklebank","year":"2001","journal-title":"Health Technol Assess"},{"key":"2024102020345281000_37.6.1308.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.1.335"},{"key":"2024102020345281000_37.6.1308.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.01.008"},{"key":"2024102020345281000_37.6.1308.9","doi-asserted-by":"publisher","DOI":"10.4104\/pcrj.2009.00029"},{"key":"2024102020345281000_37.6.1308.10","doi-asserted-by":"publisher","DOI":"10.1089\/089426803769017613"},{"key":"2024102020345281000_37.6.1308.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.11.003"},{"key":"2024102020345281000_37.6.1308.12","first-page":"101","article-title":"Problems patients have using pressurized aerosol inhalers","volume":"63","author":"Crompton","year":"1982","journal-title":"Eur J Respir Dis"},{"key":"2024102020345281000_37.6.1308.13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"5","author":"Labiris","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"2024102020345281000_37.6.1308.14","doi-asserted-by":"publisher","DOI":"10.1093\/annhyg\/38.inhaled_particles_VII.15"},{"key":"2024102020345281000_37.6.1308.15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1183\/09031936.95.08040590","article-title":"Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations","volume":"8","author":"Williamson","year":"1995","journal-title":"Eur Respir J"},{"key":"2024102020345281000_37.6.1308.16","first-page":"57","article-title":"Effects of various inhalation modes on the deposition of radioactive pressurized aerosols","volume":"63","author":"Newman","year":"1982","journal-title":"Eur J Respir Dis Suppl"},{"key":"2024102020345281000_37.6.1308.17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200410-1414OC"},{"key":"2024102020345281000_37.6.1308.18","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10092127"},{"issue":"Suppl. 1","key":"2024102020345281000_37.6.1308.19","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1089\/jam.1996.9.Suppl_1.S-77","article-title":"In vivo measurements of aerosol dose and distribution: clinical relevance","volume":"9","author":"Laube","year":"1996","journal-title":"J Aerosol Med"},{"key":"2024102020345281000_37.6.1308.20","first-page":"1162","article-title":"The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination","volume":"50","author":"Laube","year":"2005","journal-title":"Respir Care"},{"key":"2024102020345281000_37.6.1308.21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1164\/ajrccm\/136.6.1445","article-title":"Quantitative deposition of aerosolized gentamicin in cystic fibrosis","volume":"136","author":"Ilowite","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2024102020345281000_37.6.1308.22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jappl.1976.40.3.468","article-title":"Aerosol penetrance: a sensitive index of peripheral airways obstruction","volume":"40","author":"Dolovich","year":"1976","journal-title":"J Appl Physiol"},{"key":"2024102020345281000_37.6.1308.23","first-page":"397","article-title":"Pulmonary aerosol deposition in chronic bronchitis: IPPB versus quiet breathing","volume":"115","author":"Dolovich","year":"1977","journal-title":"Am Rev Respir Dis"},{"key":"2024102020345281000_37.6.1308.24","first-page":"541","article-title":"Autoradiographic visualisation of \u03b2-adrenoceptor subtype in human lung","volume":"132","author":"Carstairs","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"2024102020345281000_37.6.1308.25","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1164\/ajrccm\/141.6.1559","article-title":"Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung","volume":"141","author":"Mak","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"2024102020345281000_37.6.1308.26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1164\/ajrccm.154.3.8810618","article-title":"Glucocorticoid receptor localization in normal and asthmatic lung","volume":"154","author":"Adcock","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102020345281000_37.6.1308.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032158"},{"key":"2024102020345281000_37.6.1308.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.12.052"},{"key":"2024102020345281000_37.6.1308.29","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.94.07122185"},{"key":"2024102020345281000_37.6.1308.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.05.015"},{"key":"2024102020345281000_37.6.1308.31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0002-9343(80)80016-7","article-title":"The adequacy of inhalation of aerosol from canister nebulizers","volume":"69","author":"Shim","year":"1980","journal-title":"Am J Med"},{"key":"2024102020345281000_37.6.1308.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.011"},{"key":"2024102020345281000_37.6.1308.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.11.700"},{"key":"2024102020345281000_37.6.1308.34","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.05.00009607"},{"key":"2024102020345281000_37.6.1308.35","doi-asserted-by":"publisher","DOI":"10.4104\/pcrj.2009.00025"},{"key":"2024102020345281000_37.6.1308.36","unstructured":"Maugh TH 2nd . FDA phasing out asthma inhalers using CFC propellant. http:\/\/latimesblogs.latimes.com\/booster_shots\/2010\/04\/the-fda-phasing-out-certain-asthma-inhalers.html Date last updated: April 13, 2010. Date last accessed: March, 29 2011"},{"key":"2024102020345281000_37.6.1308.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(99)00133-7"},{"key":"2024102020345281000_37.6.1308.38","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.12061346"},{"key":"2024102020345281000_37.6.1308.39","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.2.510"},{"key":"2024102020345281000_37.6.1308.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70016-3"},{"key":"2024102020345281000_37.6.1308.41","doi-asserted-by":"publisher","DOI":"10.1089\/jam.2005.18.379"},{"key":"2024102020345281000_37.6.1308.42","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200948060-00001"},{"key":"2024102020345281000_37.6.1308.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01493.x"},{"key":"2024102020345281000_37.6.1308.44","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00095906"},{"key":"2024102020345281000_37.6.1308.45","doi-asserted-by":"publisher","DOI":"10.1136\/thx.46.10.712"},{"key":"2024102020345281000_37.6.1308.46","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1183\/09031936.93.04020172","article-title":"The use of a new breath-actuated inhaler by patients with severe airflow obstruction","volume":"4","author":"Fergusson","year":"1991","journal-title":"Eur Respir J"},{"key":"2024102020345281000_37.6.1308.47","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.8.835"},{"key":"2024102020345281000_37.6.1308.48","doi-asserted-by":"publisher","DOI":"10.1089\/08942680152484126"},{"key":"2024102020345281000_37.6.1308.49","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00051106"},{"key":"2024102020345281000_37.6.1308.50","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1183\/09031936.03.00087803","article-title":"Distribution of technetium-99m-labelled QVAR delivered using an Autohaler device in children","volume":"21","author":"Devadason","year":"2003","journal-title":"Eur Respir J"},{"key":"2024102020345281000_37.6.1308.51","doi-asserted-by":"publisher","DOI":"10.1517\/17425240802637862"},{"key":"2024102020345281000_37.6.1308.52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1081\/JAS-54625","article-title":"Bacterial contamination of spacer devices used by asthmatic children","volume":"42","author":"Cohen","year":"2005","journal-title":"J Asthma"},{"key":"2024102020345281000_37.6.1308.53","first-page":"646","article-title":"Special problems in aerosol delivery: neonatal and pediatric considerations","volume":"45","author":"Cole","year":"2000","journal-title":"Respir Care"},{"key":"2024102020345281000_37.6.1308.54","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2125.2000.00251.x","article-title":"Reducing electrostatic charge on spacer devices and bronchodilator response","volume":"50","author":"Wildhaber","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"2024102020345281000_37.6.1308.55","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.13367399"},{"key":"2024102020345281000_37.6.1308.56","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00.16585000"},{"key":"2024102020345281000_37.6.1308.57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2125.1995.tb04538.x","article-title":"The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler","volume":"40","author":"Barry","year":"1995","journal-title":"Brit J Clinic Pharm"},{"key":"2024102020345281000_37.6.1308.58","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2007.0634"},{"key":"2024102020345281000_37.6.1308.59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1368-5031.2004.00123.x"},{"key":"2024102020345281000_37.6.1308.60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2007.01593.x"},{"key":"2024102020345281000_37.6.1308.61","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(94)00388-L"},{"key":"2024102020345281000_37.6.1308.62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/jam.1993.6.99","article-title":"The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers \u2013 implications for in vitro testing","volume":"6","author":"Clark","year":"1993","journal-title":"J Aerosol Med"},{"key":"2024102020345281000_37.6.1308.63","unstructured":"Chrystyn H . Effects of device design on patient compliance: comparing the same drug in different devices.. In: Dalby R N Byron P R Peart J , eds. Respiratory Drug Delivery Europe 2009 Davis Healthcare International Publishing 2009:105\u2013116."},{"key":"2024102020345281000_37.6.1308.64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/psb.529","article-title":"What you need to know about inhalers and how to use them","volume":"20","author":"Chrystyn","year":"2009","journal-title":"Prescriber"},{"key":"2024102020345281000_37.6.1308.65","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(97)90009-3"},{"key":"2024102020345281000_37.6.1308.66","doi-asserted-by":"publisher","DOI":"10.1089\/08942680252908593"},{"key":"2024102020345281000_37.6.1308.67","doi-asserted-by":"publisher","DOI":"10.1136\/adc.65.3.308"},{"key":"2024102020345281000_37.6.1308.68","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363220-00010"},{"key":"2024102020345281000_37.6.1308.69","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2000.0959"},{"key":"2024102020345281000_37.6.1308.70","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.115.4.952","article-title":"Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates","volume":"115","author":"Newhouse","year":"1995","journal-title":"Chest"},{"key":"2024102020345281000_37.6.1308.71","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.11020350"},{"key":"2024102020345281000_37.6.1308.72","doi-asserted-by":"publisher","DOI":"10.1089\/089426801316970268"},{"key":"2024102020345281000_37.6.1308.73","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10092105"},{"key":"2024102020345281000_37.6.1308.74","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20109"},{"key":"2024102020345281000_37.6.1308.75","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afl174"},{"key":"2024102020345281000_37.6.1308.76","doi-asserted-by":"publisher","DOI":"10.1136\/adc.61.1.11"},{"key":"2024102020345281000_37.6.1308.77","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00220001"},{"key":"2024102020345281000_37.6.1308.78","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.95.08071214"},{"key":"2024102020345281000_37.6.1308.79","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1136\/thx.52.2008.S92","article-title":"Selecting and using nebulizer equipment","volume":"52","author":"Kendrick","year":"1997","journal-title":"Thorax"},{"key":"2024102020345281000_37.6.1308.80","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00096802"},{"key":"2024102020345281000_37.6.1308.81","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016282502954"},{"key":"2024102020345281000_37.6.1308.82","doi-asserted-by":"publisher","DOI":"10.1089\/jam.2000.13.325"},{"key":"2024102020345281000_37.6.1308.83","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.1.1.165"},{"key":"2024102020345281000_37.6.1308.84","doi-asserted-by":"publisher","DOI":"10.1080\/08982100600680733"},{"key":"2024102020345281000_37.6.1308.85","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1211\/jpp.58.7.0002","article-title":"Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers","volume":"58","author":"Elhissi","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"2024102020345281000_37.6.1308.86","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9141-z"},{"key":"2024102020345281000_37.6.1308.87","first-page":"1703","article-title":"Aerosol delivery of recombinant human DNAse I: in vitro comparison of a vibrating mesh nebulizer with a jet nebulizer","volume":"53","author":"Johnson","year":"2008","journal-title":"Respir Care"},{"key":"2024102020345281000_37.6.1308.88","doi-asserted-by":"publisher","DOI":"10.1089\/jam.2005.18.354"},{"key":"2024102020345281000_37.6.1308.89","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.10454"},{"key":"2024102020345281000_37.6.1308.90","doi-asserted-by":"publisher","DOI":"10.1089\/jam.2007.0572"},{"key":"2024102020345281000_37.6.1308.91","doi-asserted-by":"publisher","DOI":"10.1089\/jam.2007.0579"},{"key":"2024102020345281000_37.6.1308.92","unstructured":"National Asthma Education and Prevention Program, National Institutes of Health: Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Bethesda, National Institutes of Health, 2007."},{"key":"2024102020345281000_37.6.1308.93","unstructured":"Zierenberg B Eicher J Dunne S . Boehringer Ingelheim nebulizer BINEB\u00ae a new approach to inhalation therapy.. In: Dalby R Byron P R Farr S J , edsRespiratory Drug Delivery V Interpharm Press 1996:187\u2013193."},{"key":"2024102020345281000_37.6.1308.94","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/jam.1999.12.Suppl_1.S-19","article-title":"Optimizing the in vitro performance of Respimat\u00ae","volume":"12","author":"Zierenberg","year":"1999","journal-title":"J Aerosol Med"},{"key":"2024102020345281000_37.6.1308.95","doi-asserted-by":"publisher","DOI":"10.1021\/js950522q"},{"key":"2024102020345281000_37.6.1308.96","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.4.957"},{"key":"2024102020345281000_37.6.1308.97","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(96)00016-4"},{"key":"2024102020345281000_37.6.1308.98","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200401-033OC"},{"key":"2024102020345281000_37.6.1308.99","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043891"},{"key":"2024102020345281000_37.6.1308.100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4187\/002013209790983250","article-title":"New aerosol delivery devices for cystic fibrosis","volume":"54","author":"Kesser","year":"2009","journal-title":"Respir Care"},{"key":"2024102020345281000_37.6.1308.101","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11094-1"},{"key":"2024102020345281000_37.6.1308.102","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1164\/ajrccm.151.5.7735578","article-title":"The assessment and management of adults with status asthmaticus","volume":"151","author":"Corbridge","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102020345281000_37.6.1308.103","first-page":"119","article-title":"Modes d'administration des \u03b2-agonistes dans l'asthme. [Modes of administration of \u03b2-agonists in asthma.]","volume":"52","author":"Salmeron","year":"1996","journal-title":"Rev Pneumol Clin"},{"key":"2024102020345281000_37.6.1308.104","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/ajhp\/62.10.1053","article-title":"Automatic replacement of albuterol nebulizer therapy by metered-dose inhaler and valved holding chamber","volume":"62","author":"Hendeles","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"2024102020345281000_37.6.1308.105","doi-asserted-by":"publisher","DOI":"10.1378\/chest.91.4.614"},{"key":"2024102020345281000_37.6.1308.106","doi-asserted-by":"publisher","DOI":"10.1378\/chest.93.3.476"},{"key":"2024102020345281000_37.6.1308.107","doi-asserted-by":"publisher","DOI":"10.1378\/chest.96.6.1237"},{"key":"2024102020345281000_37.6.1308.108","first-page":"154","article-title":"Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral\/metered-dose inhaler regimen and an intravenous\/nebulizer regimen","volume":"47","author":"Shortfall","year":"2002","journal-title":"Respir Care"},{"key":"2024102020345281000_37.6.1308.109","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.5.9904119"},{"key":"2024102020345281000_37.6.1308.110","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hci084"},{"key":"2024102020345281000_37.6.1308.111","first-page":"CD006458","article-title":"Nebulized hypertonic saline solution for acute bronchiolitis in infants","volume":"4","author":"Zhang","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102020345281000_37.6.1308.112","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00166508"},{"key":"2024102020345281000_37.6.1308.113","unstructured":"European Medicines Agency (2011) Guideline on the requirements for clinical documentation for orally inhaled products (OIP) including the requirements for demonstration of therapeutic equivalence between two inhaled products for use in the treatment of asthma and chronic obstructive pulmonary disease (COPD). www.ema.europa.eu\/pdfs\/human\/ewp\/4850108en.pdf Date last updated: March 19, 2008. Date last accessed: March 24."},{"key":"2024102020345281000_37.6.1308.114","first-page":"CD000052","article-title":"Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma","volume":"2","author":"Cates","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102020345281000_37.6.1308.115","first-page":"1331","article-title":"Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients","volume":"50","author":"Dhand","year":"2005","journal-title":"Respir Care"},{"key":"2024102020345281000_37.6.1308.116","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/ajrccm.154.2.8756811","article-title":"Dose-response to bronchodilator delivered by metered-dose inhaler in ventilator-supported patients","volume":"154","author":"Dhand","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102020345281000_37.6.1308.117","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1164\/ajrccm.154.2.8756810","article-title":"Aerosol delivery from a metered-dose inhaler during mechanical ventilation. An in vitro model","volume":"154","author":"Fink","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102020345281000_37.6.1308.118","doi-asserted-by":"publisher","DOI":"10.1007\/s001340051049"},{"key":"2024102020345281000_37.6.1308.119","doi-asserted-by":"publisher","DOI":"10.1378\/chest.105.1.106"},{"key":"2024102020345281000_37.6.1308.120","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-003-1792-1"},{"key":"2024102020345281000_37.6.1308.121","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-005-2594-4"},{"key":"2024102020345281000_37.6.1308.122","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1164\/ajrccm\/145.5.1117","article-title":"Nebulizer function during mechanical ventilation","volume":"145","author":"O'Riordan","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"2024102020345281000_37.6.1308.123","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200210-1167OC"},{"key":"2024102020345281000_37.6.1308.124","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/ajrccm.163.1.2003025","article-title":"Improvement in aerosol delivery with helium-oxygen mixture during mechanical ventilation","volume":"163","author":"Goode","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102020345281000_37.6.1308.125","first-page":"817","article-title":"Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically-ventilated patients: comparison of magnitude and duration of response","volume":"45","author":"Duarte","year":"2000","journal-title":"Respir Care"},{"key":"2024102020345281000_37.6.1308.126","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1567","article-title":"Metered-dose inhaler versus nebulized albuterol in mechanically-ventilated patients","volume":"148","author":"Manthous","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"2024102020345281000_37.6.1308.127","doi-asserted-by":"publisher","DOI":"10.1007\/BF01699856"},{"key":"2024102020345281000_37.6.1308.128","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1164\/ajrccm.157.6.9609017","article-title":"Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome","volume":"157","author":"Putensen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102020345281000_37.6.1308.129","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1164\/ajrccm.153.3.8630585","article-title":"Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome","volume":"153","author":"Walmrath","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102020345281000_37.6.1308.130","doi-asserted-by":"publisher","DOI":"10.1089\/jam.2007.0574"},{"key":"2024102020345281000_37.6.1308.131","first-page":"1649","article-title":"Albuterol delivery during noninvasive ventilation","volume":"50","author":"Branconnier","year":"2005","journal-title":"Respir Care"},{"key":"2024102020345281000_37.6.1308.132","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1211\/jpp.58.11.0017","article-title":"Enhanced delivery of nebulised salbutamol during non-invasive ventilation","volume":"58","author":"Calvert","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"2024102020345281000_37.6.1308.133","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.04.012"},{"key":"2024102020345281000_37.6.1308.134","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-9-1"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09031936.00166410","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:28:40Z","timestamp":1740378520000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09031936.00166410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,10]]},"references-count":134,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,1]]},"published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.1183\/09031936.00166410"],"URL":"https:\/\/doi.org\/10.1183\/09031936.00166410","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,10]]}}}